PPD Phase I Unit is a clinical research site located in Austin, Texas, United States.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
PPD Phase I Unit has participated in 2 clinical trials.
Therapeutic areas: MRSA, SSTI, Skin and Soft Tissue Infections, Methicillin-resistant Staphylococcus Aureus.
Sponsors: Enanta Pharmaceuticals, Inc.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
PPD Phase I Unit has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
PPD Phase I Unit has 2 clinical trials on record. Their work covers MRSA, SSTI, Skin and Soft Tissue Infections, Methicillin-resistant Staphylococcus Aureus.
PPD Phase I Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.